An interventional study of Questionnaire in Chronic Disease, Patient Education as Topic and Patient Adherence, sponsored by University Hospital, Lille. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-10-17.
Sponsored by University Hospital, Lille · Not applicable, Interventional, and Supportive care
Among 55 studies in Patient Compliance with a site in France — 7 open to participants now, 9 under way, none of them phase 3. Patient Compliance · France.
Among the 55 studies in Patient Compliance with a site in France, this one is the 5th largest by enrollment of the 28 interventional ones that give a count, is the only one that started in 2017, is one of 25 with no phase, and was the 24th registered.
752 studies on the registry are indexed under Patient Compliance; 72 are open to participants now.
Browse Patient Compliance studies →7 of the 55 studies in Patient Compliance with a site in France are open now. Recruiting first, the newest first:
Nantes University Hospital · Sites in France
Ages 6–16
Hôpital le Vinatier · Sites in France
Ages 18+
University of Avignon · Sites in France
Ages 11–18
University Hospital, Angers · Sites in France
Ages 18+
Centre Georges Francois Leclerc · Sites in France
Ages 18+ · Women only
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 45 Patient Compliance studies recruiting now, 25 (56%) set no upper age limit and 13 (29%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
55 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 459 is above the median of 116 across 527 interventional studies indexed under Patient Compliance.
Median enrollment 179 across the 28 interventional studies, 134 across the 27 observational. Of the 39 that completed or were terminated, 2 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 55 have an industry lead sponsor. The 10 most frequent:
University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.
University Hospital, Lille has 2 studies filed under Patient Compliance — fewer than ten, so there is no comparison to draw.
4 of the studies in Patient Compliance with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07340931Nantes University HospitalPilot Study on the Adaptation and Tolerance of Essilor® Myopia-control Spectacle Lenses | 2027-01-20 |
| NCT07811115University of AvignonAssociations Between Physical Activity and Sedentary Behavior Profiles and Carotid Intima-media Thickness in Adolescents With Obesity | 2027-03 |
| NCT05258539Assistance Publique - Hôpitaux de ParisBreast Cancer Prevention and Screening Membership | 2027-04-01 |
| NCT06781593Hôpital le VinatierCombining Light Therapy and CPAP in Depression | 2027-10-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 55 studies in Patient Compliance with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Therapeutic Patient Education (TPE) refers to programs that help patients to manage life with a chronic disease in the best possible way. In spite of the effectiveness of Therapeutic Patient Education, few patients uptake TPE when it is proposed to them. Therefore, our main aim was to identify patients' beliefs that will predict patients' uptake of TPE. According to the Health Belief Model, patient will participate in TPE if they perceive their disease as a serious threat (with possible serious complications), but which can be controlled however, and that TPE is efficient and represents little burden.
Secondary aims are as follows:
The ultimate goal of the study is to identify patients whose beliefs will not favor participation in TPE in order to accompany those patients more carefully. Best practices will be proposed according the results.
752 studies on the registry are indexed under Patient Compliance; 72 are open to participants now.
This study's enrollment of 459 is above the median of 116 across 527 interventional studies indexed under Patient Compliance.
Browse Patient Compliance studies →University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.
Compared within Patient Compliance, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Chronic Disease. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Auto and hetero questionnaire
Other: Questionnaire
Patient Self reported questionnaire filled in.
Patient's intention to participated in TPE by a questionnaire based on the Health Belief Model
Patient's participation in TPE : yes or no Participation is defined as the patient's intention to come expressly to the hospital for a first appointment dedicated to therapeutic education. The main variables of the HBM will be analyzed: perceived threat of the pathology, perceived benefits and barriers to TPE, perceived patient control of its pathology.
Time frame: Baseline (after TPE proposal)
Time limit of first proposition in TPE
Time between date of diagnostic illness and date of first first proposition in TPE
Time frame: Baseline
Timeout of first participation in TPE
Time between date of proposition and date of the program begin of TPE
Time frame: Baseline
Medical context in which TPE is proposed
Medical context in acute phase versus phase of stabilization of the pathology
Time frame: Baseline
Consultation And Relational Empathy (CARE) questionnaire
The patient's perceived empathy of the professional (s) who offered the TPE will be assessed by the CARE questionnaire
Time frame: Baseline
Visual analog scale for intention to participated
Visual analog scale ranging from 0 "not at all intending to participate" to 100 "very strong intention to participate Measurement of the patient's intention to participate in the proposed TPE program
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2017 to primary completion in Sep 2020, 32 months.
Of 224 non-industry interventional studies with no phase under Patient Compliance, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 37. This study's 32 months is above that.
Counting every sponsor, half of 237 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.